NVGCT

The aim of the Netherlands Society of Gene & Cell Therapy is to promote both fundamental and translational research on gene & cell therapies. By bringing together all stakeholders (i.e. researchers, patients, physicians, government and regulatory authorities) the society aims to contribute to the swift development of new therapies for life-threatening diseases, including inherited diseases as well as acquired diseases such as cancer and cardiovascular diseases.

To achieve this, the society actively promotes:

  • Exchange of information and expertise between the various stakeholders
  • Public awareness of the status and possibilities of gene & cell therapy by organizing public events, workshops and lectures
  • Educational & Research-oriented sessions for researchers in the gene & cell therapy field (e.g. organisation of Spring Symposium)

Calendar

News

RNA Horizons 2025 Therapeutic Symposium

We would like to share the upcoming RNA Horizons 2025 Therapeutics Symposium, taking place on October 29-31, 2025 in Palermo, Sicily. This premier event is recommended to researchers with an interest in RNA therapeutics. It explores the latest advancements in the field, from established modalities to emerging areas like ASOs and RNA structure-based therapies. Discussions …

Launch of new guidebook for ATMP developers

FAST has collaborated with experts to create a renewed and expanded guidebook for developing Advanced Therapy Medicinal Products (ATMPs) in the Netherlands. Tailored to both academic and commercial developers, the guidebook delivers essential guidance on European and Dutch regulations and provides a roadmap to navigate the complex ATMP development process. A guide to the ATMP …